Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer - Top-Institutions - MDSpire

Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer

  • By

  • Muhammad Talal Amin

  • Louis Coussement

  • Tim De Meyer

  • June 9, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, TN

    Key Differentiators

    • Oncology

  • #4

    City of Hope National Medical Center
    City of Hope National Medical Center

    Duarte, CA

    Key Differentiators

    • Oncology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Oncology

Original Source(s)

Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer

  • by Muhammad Talal Amin, Louis Coussement, Tim De Meyer

  • June 9, 2026

Related Content

Tagraxofusp in adult blastic plasmacytoid dendritic cell neoplasm: clinical trials and real-world outcomes: a systematic review

Splenic flexure colon cancer may represent a distinct prognostic subtype associated with elevated systemic inflammation and impaired nutritional status

Parvovirus B19 infection preceding the diagnosis of childhood myelodysplastic syndrome with low blasts: a case report